Nicholas “Nick” Diamond focuses his practice on federal and international legal matters within the food, health care, life sciences, medical device, and technology sectors. He helps clients navigate complex regulatory and corporate matters across these dynamic sectors in the United States and abroad.
Nick advises on a spectrum of FDA-regulated products, including: animal drugs; cosmetics; drug compounding; food (both human and animal), beverage, and dietary supplements; human pharmaceuticals and biotechnology products; medical devices (especially AI/ML-enabled SaMD) and diagnostics; and vaccines. Nick’s focus also extends to products regulated by other federal agencies, such as USDA, CPSC, and FTC.
Nick regularly advises clinical laboratories, research institutions, and CROs on FDA-related issues from preclinical development through post-market activities. His background as a trained bioethicist, combined with his experience teaching bioethics at leading academic institutions, enhances his ability to assist clients with ethical considerations that can emerge during research and product commercialization.
With a deep understanding of international markets, Nick supports clients with ventures outside the United States, including in Canada, the Asia-Pacific, the European Union and United Kingdom, Latin America, and the Middle East. He counsels businesses looking to penetrate new markets or expand their global footprint, while navigating cross-border governance priorities relating to anti-corruption, business and human rights, and data privacy.
Apart from his practice, Nick is a passionate educator. He holds positions as an adjunct professor at both the Georgetown University Law Center and the University of Houston Law Center. Nick is also an accomplished writer whose work has been featured in leading law reviews, scholarly journals, and well-respected media publications worldwide.
